DGailMcCarverMD
Neonat/Perinatology • Milwaukee, WIProfessor, Pediatrics, Medical College of Wisconsin
Are you Dr. McCarver?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Children's Hospital Of Wisconsin
9000 West Wisconsin Avenue
Milwaukee, WI 53226Phone+1 414-805-3666
Summary
- Dr. D McCarver, MD is a neonatologist in Milwaukee, Wisconsin. She is currently licensed to practice medicine in Wisconsin. She is a Professor at Medical College of Wisconsin.
Education & Training
Vanderbilt University Medical CenterFellowship, Clinical Pharmacology, 1986 - 1988
Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 1978 - 1979
University of Tennessee Health Science Center College of MedicineClass of 1978
Certifications & Licensure
WI State Medical License 1999 - 2015- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Neonatal-Perinatal Medicine
Publications & Presentations
PubMed
- 36 citationsTrichloroethylene Decreases Heat Shock Protein 90 Interactions with Endothelial Nitric Oxide Synthase: Implications for Endothelial Cell ProliferationJingsong Ou, Zhijun Ou, D. Gail McCarver, Ronald N. Hines, Keith T. Oldham
Toxicological Sciences. 2003-05-01 - 51 citationsProximity of residence to trichloroethylene-emitting sites and increased risk of offspring congenital heart defects among older women.Jennifer S. Yauck, Marsha Malloy, Kathleen Blair, Pippa Simpson, D. Gail McCarver
Birth Defects Research. Part A, Clinical and Molecular Teratology. 2004-10-01 - 222 citationsDevelopmental expression of human hepatic CYP2C9 and CYP2C19.Sevasti B. Koukouritaki, Jason Manro, Sandra A. Marsh, Jeffrey C. Stevens, Allan E. Rettie
The Journal of Pharmacology and Experimental Therapeutics. 2004-03-01
Grant Support
- Factors Determining Bisphenol A Disposition In Human InfantsNational Institute Of Environmental Health Sciences2010–2012
- CYP2E1 And ADH In Human TRI TeratogenecityNational Center For Research Resources2005–2006
- Role Of CYP2E1 And ADH In Human TRI TeratogenicityNational Institute Of Environmental Health Sciences2001–2005
- CYP2E1 Polymorphism--Mechanism And Impact On DiseaseNational Institute On Alcohol Abuse And Alcoholism1999–2000
- CYP2E1 Polymorphism--Mechanism And Impact On DiseaseNational Institute On Alcohol Abuse And Alcoholism1998–1999
